Newsroom

Picture of the current DZIF Executive Board

News

Professor Thomas Pietschmann, Scientific Co-Director of the Helmholtz Centre for Infection Research (HZI), Professor of Experimental Virology at Hannover Medical School (MHH) and virologist at TWINCORE - Centre for Experimental and Clinical Infection Research—a joint institution of the MHH and the HZI—has been elected to the DZIF Executive Board by the members of the German Center for Infection Research (DZIF). Pietschmann's term of office begins on 8 November 2023.

09.11.2023

TWINCORE

HZI Campus

News

In the context of the tenure negotiations for Drug Bioinformatics Professor Olga Kalinina, the Klaus Faber Foundation is providing €100,000 to the "bioINFpro" project, thereby enabling her long-term stay at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Saarland University. Since 2018, Prof Kalinina, as a Klaus Faber Foundation Professor, has been involved in bioinformatic research on new drugs against infectious diseases. The confirmation of project funding took place on November 6, 2023, on the campus of Saarland University. HIPS is a site of the Helmholtz Centre for Infection Research in cooperation with Saarland University.

06.11.2023

HIPS

Graphic of Cryo-electron microscope reconstruction of the antigen binding region

News

Antibiotic-resistant bacteria pose a major challenge to healthcare systems worldwide. Due to numerous resistance mechanisms, infections with the pathogen Pseudomonas aeruginosa are particularly feared. Researchers at the German Center for Infection Research (DZIF), the University Hospital Cologne, the Helmholtz Centre for Infection Research in Braunschweig and the University Medical Center Hamburg-Eppendorf have now discovered antibodies that could lead to a highly potent treatment option of acute and chronic infections with P. aeruginosa. The study was published in the prestigious scientific journal Cell.

02.11.2023

HZI Campus

Crystal structure of LasB in complex with a ligand

News

Researchers from the Department of Drug Design and Optimisation have developed molecules that can drastically reduce the pathogenic effects of the hospital germ Pseudomonas aeruginosa. In this interview, the authors Dr. Jörg Haupenthal and Dr. Andreas Kany tell us why P. aeruginosa is such a big problem, provide insights into their novel treatment strategy and explain which steps are still necessary before clinical use. Their work was published in the journal ACS Central Science.

30.10.2023

HIPS

HZI Campus

News

The Academy of Sciences in Hamburg awards Prof Fabian Leendertz, Director of the Helmholtz Institute for One Health (HIOH), the Hamburg Science Award 2023 for his fundamental work in the field of zoonotic infectious diseases using the One Health concept. Leendertz's research contributes significantly to a better understanding of the mechanisms of disease development and transmission between humans, animals and the environment. The One Health surveillance studies conducted by the Helmholtz Institute for One Health, a site of the Helmholtz Centre for Infection Research (HZI), in sub-Saharan Africa play a crucial role in the prevention of epidemics and pandemics.

13.10.2023

HIOH

News

The Alliance of Science Organisations in Germany expresses its deepest condolences for the victims of the terrorist attacks on Israel. In particular, our sympathy is with our friends and colleagues in the Israeli scientific community. Israel has been and will always be a prime partner for the German research and innovation community.

12.10.2023

HZI Campus

Back to the first page
...
34
35
36
37
...
151

HZI in the media

der Medizinischen Hochschule Hannover und des Helmholtz-Zentrums für Infektionsforschung wollen seltene rheumatische Erkrankungen des

02.02.2026

Niedersächsisches Landesjustizportal

MWK) und der VolkswagenStiftung hat das Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig das Großprojekt HUMAN ...

02.02.2026

juraforum.de

... an anderen Forschungseinrichtungen gearbeitet, beispielsweise am Helmholtz-Institut für Pharmazeutische Forschung Saarland. Was sind die ...

02.02.2026

Deutschlandfunk

waren mehrere Forschungseinrichtungen beteiligt, darunter das Helmholtz-Zentrum für Infektionsforschung . Die Ergebnisse erschienen im

02.02.2026

Münchner Merkur

Medicine (CiiM), which is a joint institution of the Helmholtz Center for Infection Research (HZI) and Hannover Medical School (MHH). Using

29.01.2026

Medical Xpress

... stumpfen ab“, erklärt Marc Brönstrup vom Helmholtz-Zentrum für Infektionsforschung in Braunschweig. Neue Antibiotika sind dringend ...

27.01.2026

Tvinfo.de

entered an exclusive research partnership with the Helmholtz Centre for Infection Research’s HIPS institute to investigate how the skin

22.01.2026

Simply Wall St News

... der MHH, des TWINCORE Hannover und des Helmholtz-Instituts für Infektionsforschung (HZI). Ihre wissenschaftliche Expertise ...

21.01.2026

hannover.de

... auch Teil des Ecoversity-Programms der Technischen Universität Braunschweig.

GN De hlth| Source | domain www.helmholtz-hzi.

20.01.2026

Die heutigen Nachrichten

... validierte Daten der MHH und des Helmholtz-Zentrum für Infektionsforschung (HZI), die zeitnah in Fachjournalen veröffentlichet ...

19.01.2026

wallstreet:online

institutions, including Hannover Medical School and the Helmholtz Centre for Infection Research in Germany, the University of Duisburg Essen

18.01.2026

Thailandmedical

Lange , Kommissarische Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung (HZI), Braunschweig, gegenüber dem

16.01.2026

Medscape

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.